{"nct_id":"NCT04003636","title":"Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2019-09-24","start_date_type":"ACTUAL","primary_completion_date":"2022-12-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}